For the quarter ending 2025-11-30, CHSCL had $58,261K increase in cash & cash equivalents over the period. -$453,816K in free cash flow.
| Cash Flow | 2025-11-30 | 2025-08-31 |
|---|---|---|
| Net income (loss) | 260,457 | 597,995 |
| Depreciationdepletionandamortizationincludingmajormaintenance | - | 651,426 |
| Depreciation and amortization | 170,836 | - |
| Income (loss) from equity method investments, net of dividends or distributions | 79,998 | 60,961 |
| Provision for current expected credit losses | 4,183 | 6,136 |
| Deferred taxes | -11,361 | 38,744 |
| Other, net | -12,764 | -55,668 |
| Receivables | 375,580 | -6,999 |
| Inventories | 1,057,235 | 53,184 |
| Accounts payable and accrued expenses | 844,775 | -276,114 |
| Other liabilities | -81,131 | -142,098 |
| Net cash provided by (used in) operating activities | -337,818 | 635,787 |
| Acquisition of property, plant and equipment | 115,998 | 728,575 |
| Proceeds from disposition of property, plant and equipment | 4,468 | 34,438 |
| Expenditures for major repairs | 3,984 | 271,380 |
| Payments to acquire investments | 156,968 | 0 |
| Chscapitalpaymentsforproceedsfromloansreceivable | - | 169,072 |
| Proceeds from sale of other investments | 135 | 513,305 |
| Payments to acquire businesses, net of cash acquired | - | 237,174 |
| Changes in chs capital notes receivable, net | -27,130 | - |
| Other investing activities, net | 2,653 | 22,137 |
| Net cash provided by (used in) investing activities | -247,870 | -880,595 |
| Proceeds from notes payable and long-term debt | - | 19,038,369 |
| Proceeds from lines of credit and long-term borrowings | 4,248,656 | - |
| Payments on lines of credit, long-term borrowings and capital lease obligations | 3,548,767 | 18,512,827 |
| Preferred stock dividends paid | 42,167 | 168,668 |
| Redemptions of equities | 13,759 | 287,683 |
| Cash patronage dividends paid | - | 300,358 |
| Other financing activities, net | 246 | 600 |
| Net cash provided by (used in) financing activities | 644,209 | -230,567 |
| Effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents | -260 | 773 |
| Cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect | 58,261 | -474,602 |
| Cash and cash equivalents at beginning of period | 399,260 | 873,862 |
| Cash and cash equivalents at end of period | 457,521 | 399,260 |
CHS INC (CHSCL)
CHS INC (CHSCL)